General Info

Innovoimmune Biotherapeutics, Inc. is a biotechnology company specializing in the exploratory development and discovery of specialty drugs. It is engaged in the development of new proprietary oral small molecule NME immunomodulatory drugs for treating immunoinflammatoryÊand auto immuneÊdiseases. The objective of the company is the development of NME immunotherapies against certain specific biotargets, which are directed against the signal transduction mechanisms and chemokine/cytokine network. It focuses on drug discovery and early drug development so as to deliver novel treatments to individuals who suffer from immunoinflammatory and autoimmune diseases. The company is based at Brooklyn, New York, and extends its services to Prospect Lefferts Gardens, Central Brooklyn, and Flatbush.